Antiretroviral drug resistance surveillance among treatment-naive human immunodeficiency virus type 1-infected individuals in Angola: Evidence for low level of transmitted drug resistance

Inês Bártolo, Cheila Rocha, José Bartolomeu, António Gama, Marlene Fonseca, Ana Mendes, Filipa Cristina, Sven Thamm, Marta Epalanga, Patrícia Cavaco Silva, Nuno Taveira

Research output: Contribution to journalArticlepeer-review

19 Citations (Scopus)

Abstract

The prevalence of transmitted human immunodeficiency virus type 1 drug resistance in Angola in 2001 in 196 untreated patients was investigated. All subtypes were detected, along with unclassifiable and complex recombinant strains. Numerous new polymorphisms were identified in the reverse transcriptase and protease. Two (1.6%) unrelated patients harbored nucleoside reverse transcriptase inhibitor- and nonnucleoside reverse transcriptase inhibitor-resistant viruses (mutations: M41L, D67N, M184V, L210W, T215Y or T215F, and K103N). Continued surveillance of drug resistance is required for maximization of ART efficacy in Angola.

Original languageEnglish
Pages (from-to)3156-3158
Number of pages3
JournalAntimicrobial Agents and Chemotherapy
Volume53
Issue number7
DOIs
Publication statusPublished - Jul 2009

Fingerprint

Dive into the research topics of 'Antiretroviral drug resistance surveillance among treatment-naive human immunodeficiency virus type 1-infected individuals in Angola: Evidence for low level of transmitted drug resistance'. Together they form a unique fingerprint.

Cite this